Business
Why the Orthocell (ASX:OCC) share price is edging higher today
The Orthocell Ltd (ASX: OCC) share price is edging higher today. This comes after the company announced it has completed an important step to obtaining its commercial licence in Australia for its CelGro medical device.
During market open, the Orthocell share price reached as high as 43.5 cents. However, at the time of writing, the company’s shares have slightly retreated to 42.5 cents, up 1.2%.
Quick take on Orthocell
Orthocell focuses on the development and commercialisation of novel collagen medical devices and cellular therapies.
Its lead product, CelGro, facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications. This includes treating defects in areas of the body such as…
-
Noosa News11 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General22 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News24 hours agoPeak body calls for national oversight of ADHD diagnoses during growth trend as GP powers expand
-
General23 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money